BioDelivery Sciences International, Inc. (BDSI)

3.40
NASDAQ
Prev Close 3.25
Day Low/High 3.24 / 3.45
52 Wk Low/High 2.85 / 7.21
Exchange NASDAQ
Shares Outstanding 100.93B
Market Cap 328.04M
P/E Ratio 46.43
Div & Yield N.A. (N.A)

Latest News

Matching Downside Protection With Upside Potential in Akebia Therapeutics

Matching Downside Protection With Upside Potential in Akebia Therapeutics

This covered call strategy is an effective way to navigate an overbought market.

The Indices Are Doing a Poor Job of Reflecting What's Really Going On

The Indices Are Doing a Poor Job of Reflecting What's Really Going On

Here are several names I'm looking to build on further weakness.

The Pockets of Speculative Action Continue to Be Pretty Narrow

The Pockets of Speculative Action Continue to Be Pretty Narrow

I continue to be concerned about the price action of the indices but I can't complain about the stock picking.

2 Biotech Stocks to Buy on Solid Q2 Results

2 Biotech Stocks to Buy on Solid Q2 Results

Covid-19 has had a big impact on this sector, but these names have strong catalysts going into the next quarter.

No Predictions, But 2 Picks for the Second Half of 2020

No Predictions, But 2 Picks for the Second Half of 2020

BioDelivery Sciences International and Tivity Health are two candidates investors should consider going forward.

Strong Rebound From Covid-19 Meltdown Turns Bargain Hunting Into a Challenge

Strong Rebound From Covid-19 Meltdown Turns Bargain Hunting Into a Challenge

A now-overbought market leaves few values available among equities.

Eye-Catching Quarterly Results From a Trio of Companies

Eye-Catching Quarterly Results From a Trio of Companies

The first-quarter reports from Camping World, Esperion Therapeutics and BioDelivery Sciences were impressive amid coronavirus disruption.

Here's a Quartet of Small Biotechs That Could Make for Acquisition Targets

Here's a Quartet of Small Biotechs That Could Make for Acquisition Targets

Merger activity is picking up this week in the biotechnology sector and these four promising companies would be good buyout candidates.

2 Small Biopharma Stocks That Should Perk Up as Nation Returns to Work

2 Small Biopharma Stocks That Should Perk Up as Nation Returns to Work

Flexion Therapeutics and BioDelivery Sciences International have promising products that should do well once the fixation on Covid-19 treatments wanes.

These 2 Stocks Should Easily Withstand the Economic Impacts of Covid-19

These 2 Stocks Should Easily Withstand the Economic Impacts of Covid-19

DropBox and BioDelivery Sciences are names to consider during the market choppiness of the coming weeks.

Adding to My Biotech Positions When Profit-Taking Hits

Adding to My Biotech Positions When Profit-Taking Hits

Here's my strategy which has worked particularly well.

3 Small-Cap Biotech Stocks That Could Thrive in 2020

3 Small-Cap Biotech Stocks That Could Thrive in 2020

The trio of BioDelivery Sciences, Omeros and TG Therapeutics looks well-positioned to capitalize on their potential in the New Year.

3 Small Biotechs With Favorable Risk Vs. Reward Profiles

3 Small Biotechs With Favorable Risk Vs. Reward Profiles

BioDelivery Sciences International, Chiasma Inc. and TherapeticsMD all feature promising treatments.

3 Small-Caps That Look Like Bargains at Current Trading Levels

3 Small-Caps That Look Like Bargains at Current Trading Levels

The trio consists of BioDelivery Sciences International, Beazer Homes USA and Redhill Biopharma.

These Two Small-Cap Stocks Are Executing Well

These Two Small-Cap Stocks Are Executing Well

Both Digital Turbine and BioDelivery Sciences have done well in 2019.

Here's How I'm Playing an Increasingly Volatile Market With These 2 Biotechs

Here's How I'm Playing an Increasingly Volatile Market With These 2 Biotechs

I am incrementally using buy-write option orders to add some shares to core holdings.

These 3 Biotech Stocks Are Moving Closer to Profitability

These 3 Biotech Stocks Are Moving Closer to Profitability

Here are updates on small biotech/biopharma names I have profiled before.

BioDelivery Rated New Buy at SunTrust

My Post-Earnings Assessment of 2 Biotech Stocks

My Post-Earnings Assessment of 2 Biotech Stocks

Let's look at a couple of companies we have covered on these pages before.

3 Small Biotechs to Watch as Earnings Season Winds Down

3 Small Biotechs to Watch as Earnings Season Winds Down

One already is up nicely on its results, while the other two should issue reports of interest in the next few days.

Here Are 3 Small-Cap Names for Biotech Investors to Consider

Here Are 3 Small-Cap Names for Biotech Investors to Consider

We look at a slightly riskier part of the sector...that should be able to reach profitability with little to no additional funding needs.

3 Small Biotechs That Came Up Big on Thursday

3 Small Biotechs That Came Up Big on Thursday

Portola Pharmaceuticals, Flexion Therapeutics and BioDelivery Sciences delivered nice third-quarter numbers.

3 Small Biotechs Turn on the Revenue Jets

3 Small Biotechs Turn on the Revenue Jets

BioDelivery Sciences, Neos Therapeutics and Invitae Corp. are delivering big increases in sales.

5 Small Biotechs Receive Shots in the Arm

5 Small Biotechs Receive Shots in the Arm

Favorable quarterly results and FDA drug approvals should help lift these five names.

5 Small Biotechs Receive Shots in the Arm

5 Small Biotechs Receive Shots in the Arm

Favorable quarterly results and FDA drug approvals should help lift these five names.

4 Small-Caps on My Earnings Watch List

4 Small-Caps on My Earnings Watch List

We are coming my favorite part of earnings season -- when these small-caps report.

3 Biotech Stocks on Readers' Minds

3 Biotech Stocks on Readers' Minds

We answer questions about BioDelivery Sciences, Dynavax Technologies and Synergy Pharmaceuticals.

Trump's FDA: A Friendlier Biotech Sheriff

Trump's FDA: A Friendlier Biotech Sheriff

There still will be winners and losers, but the new administration's FDA is a net plus for the industry.